Dongfeng (Dan) Tan, MD

Peer-Reviewed Articles

1. Zan L, Zhang X, Shen L, Zhao Q, Tan D, Peng X, Jia Y, Li J, Liu J, Zhao J, Gao N, Bu P, Xi Y. Genomic landscape and potential therapeutic targets in alpha-fetoprotein-producing gastric cancer. Gastric Cancer 28(3):372-383, 2025. e-Pub 2025. PMID: 39928247.
2. S Thomas A, Lu Y, Campbell M, Thompson JA, Tan D, Faleck DM, Wang Y. Immune Checkpoint Inhibitor-Induced Colitis. Gastroenterology 168(1):21-28, 2025. e-Pub 2025. PMID: 39389184.
3. Zhou M, Zhao J, Tian M, Song S, Zhang R, Gupta S, Tan D, Shen H, Ferrari M, Li C. Retraction: Radio-photothermal therapy mediated by a single compartment nanoplatform depletes tumor initiating cells and reduces lung metastasis in the orthotopic 4T1 breast tumor model. Nanoscale 15(34):14268, 2023. e-Pub 2023. PMID: 37592914.
4. Kuang AG, Sperling G, Liang TZ, Lu Y, Tan D, Bollin K, Johnson DB, Manzano JM, Shatila M, Thomas AS, Thompson JA, Zhang HC, Wang Y. Sclerosing mesenteritis following immune checkpoint inhibitor therapy. J Cancer Res Clin Oncol 149(11):9221-9227, 2023. e-Pub 2023. PMID: 37195298.
5. Abu-Sbeih H, Tang T, Ali FS, Ma W, Shatila M, Luo W, Tan D, Tang C, Richards DM, Ge PS, Thomas AS, Wang Y. Clinical Features and Management of Acute and Chronic Radiation-Induced Colitis and Proctopathy. Cancers (Basel) 15(12), 2023. e-Pub 2023. PMID: 37370770.
6. Wilhelm AB, Cunningham AG, Kassab C, Fitz EC, Dong J, Radhakrishnan RS, Ranganathan S, Tan D, Stevenson HL. Pediatric combined hepatocellular-cholangiocarcinoma (cHCC-CC) with neuroendocrine features: distinguishing genetic alterations detected by chromosomal microarray. Diagn Pathol 18(1):20, 2023. e-Pub 2023. PMID: 36782322.
7. Thomas AR, Liu C, Tong YT, Tan D, Altan M, Siddiqui BA, Shatila M, Khan A, Thomas AS, Wang Y. Characteristics and outcomes of cancer patients with pre-existing microscopic colitis after exposure to PD-1 and PD-L1 inhibitors. J Cancer Res Clin Oncol 149(8):5429-5436, 2023. e-Pub 2022. PMID: 36451045.
8. Mathew A, Shatila M, Lai Z, Tan D, Oliva ICG, Wang J, Alhalabi O, Zhang HC, Thomas A, Wang Y. Characteristics of appendicitis after immune checkpoint inhibitor therapy among cancer patients. J Cancer Res Clin Oncol 149(8):4591-4599, 2023. e-Pub 2022. PMID: 36163559.
9. Dutra BES, Wei D, Tan D, Alasadi M, Zhang HC, Thomas A, Thomas AS, Richards DM, Wang Y. Clinical Characteristics and Outcomes of Patients with Positive Celiac Serology and Cancer Therapy Exposure, 2023. e-Pub 2023.
10. Thomas AR, Liu C, Tong YT, Tan D, Altan M, Siddiqui BA, Shatila M, Khan A, Thomas AS, Wang Y. Characteristics and outcomes of cancer patients with pre-existing microscopic colitis after exposure to PD-1 and PD-L1 inhibitors, 2023. e-Pub 2023.
11. Panneerselvam K, Szafron D, Amin RN, Wei D, Tan D, Altan M, Okhuysen PC, Shatila M, Raju GS, Thomas AS, Wang Y. Cytomegalovirus infection among patients with cancer receiving immune checkpoint inhibitors. Ann Gastroenterol 35(5):522-531, 2022. e-Pub 2022. PMID: 36061160.
12. Chen R, Li J, Fujimoto J, Hong L, Hu X, Quek K, Tang M, Mitra A, Behrens C, Chow CW, Jiang P, Little LD, Gumbs C, Song X, Zhang J, Tan D, Heymach JV, Wistuba I, Futreal PA, Gibbons DL, Byers LA, Zhang J, Reuben A. Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma. J Exp Clin Cancer Res 41(1):172, 2022. e-Pub 2022. PMID: 35546239.
13. Wang J, Wang WL, Sun H, Huo L, Wu Y, Chen H, Gan Q, Meis JM, Maloney N, Lazar AJ, Yoon EC, Albarracin CT, Krishnamurthy S, Middleton LP, Resetkova E, Yu W, Tan D, Lu W, Solis Soto LM, Wang S, Wistuba II, Parwani AV, Prieto VG, Sahin AA, Li Z, Ding Q. Expression of TRPS1 in phyllodes tumor and sarcoma of the breast. Hum Pathol 121:73-80, 2022. e-Pub 2022. PMID: 35063444.
14. Luo W, Nagaria TS, Sun H, Ma J, Lombardo JL, Bassett R, Cao AC, Tan D. Expression and Potential Prognostic Value of SOX9, MCL-1 and SPOCK1 in Gastric Adenocarcinoma. Pathol Oncol Res 28:1610293, 2022. e-Pub 2022. PMID: 35221802.
15. Dutra, BE, Wei, D, Tan, D, Alasadi, M, Zhang, HC, Thomas, A, Thomas, AS, RIchards, DM, Wang, Y. Clinical Characteristics and Outcomes of Patients with Positive Celiac Serology and Cancer Therapy Exposure. Journal of Cancer 13(3):815-822, 2022. e-Pub 2022. PMID: 35154450.
16. Panneerselvam K, Amin RN, Wei D, Tan D, Lum PJ, Zhang HC, Richards DM, Altan M, Grivas P, Thompson JA, Thomas AS, Wang Y. Clinicopathologic Features, Treatment Response, and Outcomes of Immune Checkpoint Inhibitor-Related Esophagitis. J Natl Compr Canc Netw 19(8):1-9, 2021. e-Pub 2021. PMID: 34102607.
17. Ai D, Yao J, Yang F, Huo L, Chen H, Lu W, Soto LMS, Jiang M, Raso MG, Wang S, Bell D, Liu J, Wang H, Tan D, Torres-Cabala C, Gan Q, Wu Y, Albarracin C, Hung MC, Meric-Bernstam F, Wistuba II, Prieto VG, Sahin AA, Ding Q. TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer. Mod Pathol 34(4):710-719, 2021. e-Pub 2021. PMID: 33011748.
18. Cherng HJ, Jain N, Thakral B, Muzzafar T, Miranda RN, Tan D, Rashid A, Kalhor N, Hahn AW, Byers LA, Parseghian CM, Ferrajoli A, Pemmaraju N. Metastatic lung adenocarcinoma mimicking Richter transformation in a patient with chronic lymphocytic leukemia. Leuk Res 98:106445, 2020. e-Pub 2020. PMID: 32937250.
19. Zhang C, Zhang L, Xu T, Xue R, Yu L, Zhu Y, Wu Y, Zhang Q, Li D, Shen S, Tan D, Bai F, Zhang H. Mapping the spreading routes of lymphatic metastases in human colorectal cancer. Nat Commun 11(1):1993, 2020. e-Pub 2020. PMID: 32332722.
20. Peng Y, Thomas AS, Wei D, Tan D, Wang Y. An Aggressive Approach Toward a Case of Refractory Ulcerative Colitis With Uncertain Etiology in the Context of Chronic Myeloid Leukemia. Inflamm Bowel Dis 26(4):e26-e27, 2020. e-Pub 2020. PMID: 32016290.
21. Chen E, Abu-Sbeih H, Thirumurthi S, Mallepally N, Khurana S, Wei D, Altan M, Morris VK, Tan D, Barcenas CH, Wang Y. Clinical characteristics of colitis induced by taxane-based chemotherapy. Ann Gastroenterol 33(1):59-67, 2020. e-Pub 2020. PMID: 31892799.
22. Zuo X, Deguchi Y, Xu W, Liu Y, Li HS, Wei D, Tian R, Chen W, Xu M, Yang Y, Gao S, Jaoude JC, Liu F, Chrieki SP, Moussalli MJ, Gagea M, Sebastian MM, Zheng X, Tan D, Broaddus R, Wang J, Ajami NJ, Swennes AG, Watowich SS, Shureiqi I. PPARD and Interferon Gamma Promote Transformation of Gastric Progenitor Cells and Tumorigenesis in Mice. Gastroenterology 157(1):163-178, 2019. e-Pub 2019. PMID: 30885780.
23. Zan L, Chen J, Tan D. Highly agglutinative staphylococcin therapy for malignant pleural effusions: a systematic literature review and meta-analysis. International Journal of Cancer Research & Therapy 3(1):1-11, 2018. e-Pub 2018.
24. Yan D, Jigeng B, Yuping Z, Jie SG, Yan Z, Tan D. Comparison of Three Screening Methods for Cervical Cancer in China - A Systematic Study of 3,300 Cases in Rural Areas of Shanxi Province. J Cytol Histol 8(5):492, 2017. e-Pub 2017.
25. Cui J, Yang L, Guo L, Shao Y, Tan D, Li N, Zhang H. The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy. Oncotarget 8(23):37845-37854, 2017. e-Pub 2017. PMID: 28103579.
26. Xia M, Xie Y, Zan L, Reddy S, Tan C, Li J, Zhou D, Tan D. Membranous staining of β-catenin and E-cadherin expression in patients with gastric cancer. International Journal of Clinical and Experimental Pathology 10(8):8980-90, 2017. e-Pub 2017.
27. Chang HR, Nam S, Kook MC, Kim KT, Liu X, Yao H, Jung HR, Lemos R, Seo HH, Park HS, Gim Y, Hong D, Huh I, Kim YW, Tan D, Liu CG, Powis G, Park T, Liang H, Kim YH. HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer. Gut 65(1):19-32, 2016. e-Pub 2016. PMID: 25410163.
28. Holmes M, Tan D. Non-type A autoimmune gastritis in a patient with IgA deficiency. Am J Digest Dis 3(1):6-10, 2016. e-Pub 2016.
29. Yan F, Liu J, Huang X, Liu Y, Zhao C, Li Z, Tan D, Zhang Y, Xue AY. Polymorphisms at the microRNA binding sites of CASP3 and CASP7 contribute to gastric adenocarcinoma susceptibility in the northeastern China population. Scientific Reports. e-Pub 2016.
30. Zhou M, Zhao J, Tian M, Song S, Zhang R, Gupta S, Tan D, Shen H, Ferrari M, Li C. Radio-photothermal therapy mediated by a single compartment nanoplatform depletes tumor initiating cells and reduces lung metastasis in the orthotopic 4T1 breast tumor model. Nanoscale 7(46):19438-47, 2015. e-Pub 2015. PMID: 26376843.
31. Shen R, Liu H, Wen J, Liu Z, Wang LE, Wang Q, Tan D, Ajani JA, Wei Q. Genetic polymorphisms in the microRNA binding-sites of the thymidylate synthase gene predict risk and survival in gastric cancer. Mol Carcinog 54(9):880-8, 2015. e-Pub 2015. PMID: 24756984.
32. Huber AR, Tan D, Sun J, Dean D, Wu T, Zhou Z. High expression of carbonic anhydrase IX is significantly associated with glandular lesions in gastroesophageal junction and with tumorigenesis markers BMI1, MCM4 and MCM7. BMC Gastroenterol 15:80, 2015. e-Pub 2015. PMID: 26156831.
33. Wang Q, Liu H, Xiong H, Liu Z, Wang LE, Qian J, Muddasani R, Lu V, Tan D, Ajani JA, Wei Q. Polymorphisms at the microRNA binding-site of the stem cell marker gene CD133 modify susceptibility to and survival of gastric cancer. Mol Carcinog 54(6):449-58, 2015. e-Pub 2015. PMID: 24302553.
34. Waters R, Agarwal A, Tan D. A case report of cytomegalovirus-induced colitis with colonic perforation 2(2):106-110, 2015. e-Pub 2015.
35. Humphries B, Wang Z, Oom AL, Fisher T, Tan D, Cui Y, Jiang Y, Yang C. MicroRNA-200b targets protein kinase Cα and suppresses triple negative breast cancer metastasis. Carcinogenesis 35(10):2254-63, 2014. e-Pub 2014. PMID: 24925028.
36. Li Y, Liu Z, Liu H, Wang LE, Onodera H, Suzuki A, Suzuki K, Wadhwa R, Elimova E, Sudo K, Shiozaki H, Estrella J, Lee JS, Song S, Tan D, Ajani JA, Wei Q. Potentially Functional Variants in the Core Nucleotide Excision Repair Genes Predict Survival in Japanese Gastric Cancer Patients. Carcinogenesis 35(9):142, 2014. e-Pub 2014. PMID: 24990617.
37. Javle M, Li Y, Tan D, Dong X, Chang P, Kar S, Li D. Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer. PLoS One 9(1):e85942, 2014. e-Pub 2014. PMID: 24465802.
38. Zhang Y, Ren H, Wang L, Ning Z, Zhuang Y, Gan J, Chen S, Zhou D, Zhu H, Tan D, Zhang H. Clinical impact of tumor-infiltrating inflammatory cells in primary small cell esophageal carcinoma. Int J Mol Sci 15(6):9718-34, 2014. e-Pub 2014. PMID: 24886814.
39. Zhou Z, Bandla S, Ye J, Xia Y, Que J, Luketich JD, Pennathur A, Peters JH, Tan D, Godfrey TE. Cyclin E involved in early stage carcinogenesis of esophageal adenocarcinoma by SNP DNA microarray and immunohistochemical studies. BMC Gastroenterol 14:78, 2014. e-Pub 2014. PMID: 24742107.
40. Liu F, Zhang Y, Shen D, Tan D. Molecular features and diagnostics of Lynch syndrome colorectal cancer. Chinese Journal of Pathology 9:208-215, 2014. e-Pub 2014.
41. Li Z, Zou X, Xie L, Dong H, Chen Y, WuX, Zhou D, Tan D, Zhang H. Prognostic Importance and Therapeutic Implications of PAK1, a Drugable Protein Kinase, in Gastroesophageal Junction Adenocarcinoma. PLoS One 8(11), 2013. e-Pub 2013.
42. Dong H, Guo H, Xie L, Wang G, Zhong X, Khoury T, Tan D, Zhang H. The metastasis-associated gene MTA3, a component of the Mi-2/NuRD transcriptional repression complex, predicts prognosis of gastroesophageal junction adenocarcinoma. PLoS One 8(5):e62986, 2013. e-Pub 2013. PMID: 23671646.
43. Xu Y, Ma H, Yu H, Liu Z, Wang LE, Tan D, Muddasani R, Lu V, Ajani JA, Wang Y, Wei Q. The miR-184 Binding-Site rs8126 T>C Polymorphism in TNFAIP2 Is Associated with Risk of Gastric Cancer. PLoS One 8(5):e64973, 2013. e-Pub 2013. PMID: 23724109.
44. Zhai Q, Yan L, Tan D, Chen R, Sun J, Gao L, Dong MQ, Wang Y, Li C. Phosphorylation-coupled proteolysis of the transcription factor MYC2 is important for jasmonate-signaled plant immunity. PLoS Genet 9(4):e1003422. e-Pub 2013. PMID: 23593022.
45. Chen WC, Maru DM, Abraham SC, Tan D, Raju GS. Endoscopic clip tamponade of bleeding: a novel adjunct technique for endoscopic mucosal resection. Endoscopy 45(2):UCTN:E104-5. e-Pub 2013. PMID: 23526499.
46. Zhou G, Chiu D, Qin D, Niu L, Cai J, He L, Tan D, Xu K. Expression of CD44v6 and integrin-β1 for the prognosis evaluation of pancreatic cancer patients after cryosurgery. Diagn Pathol 8:146, 2013. e-Pub 2013. PMID: 24004467.
47. Li Y, Liu Z, Liu H, Wang LE, Tan D, Ajani JA, Wei QY. ERCC1 and ERCC2 variants predict survival in gastric cancer patients. PLoS One 8(9):e71994, 2013. e-Pub 2013. PMID: 24023723.
48. Choy B, Bandla S, Xia Y, Tan D, Pennathur A, Luketich JD, Godfrey TE, Peters JH, Sun J, Zhou Z. Clinicopathological characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma. BMC Gastroenterol 12(1):146, 2012. e-Pub 2012.
49. Xu K, Zhou L, Liang B, Niu L, Zheng X, Xu J, Yang D, Tan D, Xu K. Safety and accuracy of percutaneous core needle biopsy in examining pancreatic neoplasms. Pancreas 41(4):649-51, 2012. e-Pub 2012. PMID: 22504382.
50. Li Q, Jia Z, Wang L, Kong X, Li Q, Guo K, Tan D, Le X, Wei D, Huang S, Mishra L, Xie K. Disruption of Klf4 in villin-positive gastric progenitor cells promotes formation and progression of tumors of the antrum in mice. Gastroenterology 142(3):531-42, 2012. e-Pub 2012. PMID: 22155367.
51. Chen Z, Wang J, Zhang H, Liu D, Li Y, Xu Y, Tan D, Chen D, Zhao X, Wang G. Topo IIα gene alterations correlated with survival in patients with diffuse large B-cell lymphoma. Eur J Clin Invest 42(3):310-20, 2012. e-Pub 2012. PMID: 21880040.
52. Choy B, Bandla S, Xia Y, Tan D, Pennathur A, Luketich JD, Godfrey TE, Peters JH, Sun J, Zhou Z. Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma. BMC Gastroenterol 12:146, 2012. e-Pub 2012. PMID: 23078618.
53. Feng W, Zhou Z, Peters JH, Khoury T, Zhai Q, Wei Q, Truong CD, Song SW, Tan D. Expression of insulin-like growth factor II mRNA-binding protein 3 in human esophageal adenocarcinoma and its precursor lesions. Arch Pathol Lab Med 135(8):1024-31, 2011. e-Pub 2011. PMID: 21809994.
54. Hu Y, Bandla S, Godfrey TE, Tan D, Luketich JD, Pennathur A, Qiu X, Hicks DG, Peters JH, Zhou Z. HER2 amplification, overexpression and score criteria in esophageal adenocarcinoma. Mod Pathol 24(7):899-907. e-Pub 2011. PMID: 21460800.
55. Dhingra S, Feng W, Brown RE, Zhou Z, Khoury T, Zhang R, Tan D. Clinicopathologic significance of putative stem cell markers, CD44 and nestin, in gastric adenocarcinoma. Int J Clin Exp Pathol 4(8):733-41, 2011. e-Pub 2011.
56. Khoury T, Chandrasekhar R, Wilding G, Tan D, Cheney RT. Tumour eosinophilia combined with an immunohistochemistry panel is useful in the differentiation of type B3 thymoma from thymic carcinoma. Int J Exp Pathol 92(2):87-96, 2011. e-Pub 2011. PMID: 21044186.
57. Qiu J, Kulkarni S, Chandrasekhar R, Rees M, Hyde K, Wilding G, Tan D, Khoury T. Effect of delayed formalin fixation on estrogen and progesterone receptors in breast cancer: a study of three different clones. Am J Clin Pathol 134(5):813-9, 2010. e-Pub 2010. PMID: 20959666.
58. Tan CH, Marcal L, Tan D, Patnana M. Magnetic resonance imaging diagnosis of iron overload in a leukemic patient after allogeneic hematopoietic stem cell transplantation. Transfusion 50(5):1113-7, 2010. e-Pub 2010. PMID: 20070618.
59. Xu B, Thong N, Tan D, Khoury T. Expression of Thyroid Transcription Factor-1 in Colorectal Carcinoma. Appl Immunohistochem Mol Morphol 18(3):244-249, 2010. e-Pub 2010. PMID: 20042854.
60. Veras E, Khurana H, Abadeer R, Tan D, Ayala A. Solitary synovial osteochondroma: a clinicopathologic review of five cases with radiographic correlation. Ann Diagn Pathol 14(2):94-99, 2010. e-Pub 2010. PMID: 20227014.
61. Smith KD, Tan D, Das P, Chang GJ, Kattepogu K, Feig BW, Skibber JM, Rodriguez-Bigas MA. Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation. Ann Surg 251(2):261-264, 2010. e-Pub 2010. PMID: 19864936.
62. Dhingra S, Li W, Tan D, Zenali M, Zhang H, Brown RE. Cell cycle biology of fibrolamellar hepatocellular carcinoma. Int J Clin Exp Pathol 3(8):792-7, 2010. e-Pub 2010. PMID: 21151393.
63. Zenali MJ, Tan D, Li W, Dhingra S, Brown R. Stemness Characteristics of Fibrolamellar Hepatocellular Carcinoma: Immunohistochemical Analysis with Comparisons to Conventional Hepatocellular Carcinoma. Ann Clin Lab Sci 40(2):126-134, 2010. e-Pub 2010. PMID: 20421623.
64. Al-Agha OM, Liu W, Chandrasekhar R, Wilding G, Tan D, Alrawi S, Khoury T. CD138 (Syndecan-1) in thymic tumors: correlation with various World Health Organization types and clinical outcome. Int J Clin Exp Pathol 3(3):280-287, 2010. e-Pub 2010. PMID: 20224726.
65. Qiu J, Kulkarni S, Chandrasekhar R, Rees M, Hyde K, Wilding G, Tan D, Khoury T. Effect of Delayed Formalin Fixation on Estrogen and Progesterone Receptors in Breast Cancer: A Study of Three Different Clones. Am J Clin Pathol 134(5):813-9, 2010. e-Pub 2010.
66. Khoury T, Malik D, Fan C, Tan D, Kulkarni S. Modified Alcian Blue Enhances the Intraoperative Diagnosis of Sentinel Lymph Node Metastasis in Invasive Lobular Carcinoma: a Prospective Study. Arch Pathol Lab Med 134(10):1513-1519, 2010. e-Pub 2010. PMID: 20923308.
67. Khoury T, Sait S, Hwang H, Chandrasekhar R, Wilding G, Tan D, Kulkarni S. Delay to formalin fixation effect on breast biomarkers. Mod Pathol 22(11):1457-67, 2009. e-Pub 2009. PMID: 19734848.
68. Guan X, Zhao H, Niu J, Tan D, Ajani JA, Wei Q. The VEGF -634G>C promoter polymorphism is associated with risk of gastric cancer. BMC Gastroenterol 9(1):77-83, 2009. e-Pub 2009. PMID: 19835575.
69. Li Q, Jia Z, Le X, Dai B, Wei D, Huang S, Tan D, Xie K. Critical role and regulation of transcription factor foxM1 expression in human gastric cancer angiogenesis and progression. Cancer Research 69(8):3501-3509, 2009. e-Pub 2009. PMID: 19351851.
70. Li W, Tan D, Zenali MJ, Brown RE. Constitutive activation of nuclear factor-kappa B (NF-kB) signaling pathway in fibrolamellar hepatocellular carcinoma. Int J Clin Exp Pathol 3(3):238-243, 2009. e-Pub 2009. PMID: 20224721.
71. Yin M, Hu Z, Tan D, Ajani J, Wei Q. Molecular epidemiology of genetic susceptibility to gastric cancer: focus on single nucleotide polymorphisms in gastric carcinogenesis. American Journal of Translational Research 1(1):44-54, 2009. e-Pub 2009. PMID: 19966937.
72. Khoury T, Alrawi S, Ramnath N, Li Q, Grimm M, Black J, Tan D. Eukaryotic initiation factor-4E and cyclin D1 expression associated with patient survival in lung cancer. Clin Lung Cancer 10(1):58-66, 2009. e-Pub 2009. PMID: 19289374.
73. Khoury T, Arshad A, Bogner P, Ramnath N, Zhang S, Chandrasekhar R, Wilding G, Alrawi S, Tan D. Apoptosis-related (survivin, Bcl-2), tumor suppressor gene (p53), proliferation (Ki-67), and non-receptor tyrosine kinase (Src) markers expression and correlation with clinicopathologic variables in 60 thymic neoplasms. Chest 136(1):220-8, 2009. e-Pub 2009. PMID: 19318677.
74. Guan X, Zhao H, Niu J, Tan D, Ajani JA, Wei Q. Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer. J Exp Clin Cancer Res 28:94-100, 2009. e-Pub 2009. PMID: 19566948.
75. Vj H, Orlando FA, Awad ZT, Tan D, Khoury T, Ahmed BH, Alrawi SJ. Genetic and molecular abnormalities in cholangiocarcinogenesis. Anticancer Res 29(4):1151-6, 2009. e-Pub 2009. PMID: 19414358.
76. Yin M, Tan D, Wei Q. Genetic variants of the XRCC1 gene and susceptibility to esophageal cancer: a meta-analysis. Int J Clin Exp Med 2(1):26-35, 2009. e-Pub 2009. PMID: 19436829.
77. Alrawi S, Stoler D, Tan D, Loree T, Khoury T, Rigual N, Bartos J, Hicks W, Nowak N, Anderson G. Genomic Instability and Clinical parameters in Head and Neck Squamous Cell Carcinoma. Journal of Experimental and Clinical Cancer Research. e-Pub 2009.
78. Truong CD, Feng W, Li W, Khoury T, Li Q, Alrawi S, Yu Y, Xie K, Yao J, Tan D. Characteristics of Epstein-Barr virus-associated gastric cancer: a study of 235 cases at a comprehensive cancer center in U.S.A. J Exp Clin Cancer Res 28(1):14-21, 2009. e-Pub 2009. PMID: 19192297.
79. Orlando FA, Tan D, Baltodano JD, Khoury T, Gibbs JF, Hassid VJ, Ahmed BH, Alrawi SJ. Aberrant crypt foci as precursors in colorectal cancer progression. J Surg Oncol 98:207-13, 2008. e-Pub 2008. PMID: 18623110.
80. Tan D, Ross WA. Colorectal polyps: clinical significance of endoscopic and pathologic correlation. Am J Clin Pathol 129(4):659-60; author reply 660, 2008. e-Pub 2008. PMID: 18431859.
81. Liang JJ, Kimchi ET, Staveley-O'Carroll KF, Tan D. Diagnostic and prognostic biomarkers in pancreatic carcinoma. Int J Clin Exp Pathol 2(1):1-10, 2008. e-Pub 2008. PMID: 18830385.
82. Ahmed BH, Ahmed A, Tan D, Awad ZT, Al-Aali AY, Kilkenny J, Orlando FA, Al-Chalabi A, Crass R, Alrawi SJ. Post-laparoscopic cholecystectomy pain: effects of intraperitoneal local anesthetics on pain control--a randomized prospective double-blinded placebo-controlled trial. Am Surg 74(3):201-9, 2008. e-Pub 2008. PMID: 18376682.
83. Yang J, Li Y, Khoury T, Alrawi S, Goodrich DW, Tan D. Relationships of hHpr1/p84/Thoc1 expression to clinicopathologic characteristics and prognosis in non-small cell lung cancer. Ann Clin Lab Sci 38(2):105-12, 2008. e-Pub 2008. PMID: 18469354.
84. Truong C, Li W, Feng W, Cagle P, Khoury R, Alrawi S, Xie K, Yao J, Tan D. Alpha-Methylacyl-CoA Racemase Experssion is Upregulated in Gastric Cancer: A Study of 249 Cases. Int J Clin Exp Pathol 1(6):518-523, 2008. e-Pub 2008. PMID: 18787636.
85. Tan D. Morphoproteomics: a novel approach to identify potential therapeutic targets in cancer patients. Int J Clin Exp Pathol 1(4):331-2, 2008. e-Pub 2008. PMID: 18787617.
86. Li W, Cagle PT, Botero RC, Liang JJ, Zhang Z, Tan D. Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma. J Exp Clin Cancer Res 27(1):2-9, 2008. e-Pub 2008. PMID: 18577240.
87. Tan D, Zander DS. Immunohistochemistry for assessment of pulmonary and pleural neoplasms: a review and update. Int J Clin Exp Pathol 1(1):19-31, 2008. e-Pub 2008. PMID: 18784820.
88. Feng W, Brown RE, Trung CD, Li W, Wang L, Khoury T, Alrawi S, Yao J, Xia K, Tan D. Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappa B pathways in human gastric adenocarcinoma. Ann Clin Lab Sci 38(3):195-209, 2008. e-Pub 2008. PMID: 18715846.
89. Li W, Tan D, Zhang Z, Liang J, Brown R. Activation of Akt-mTOR/p70S6K pathway in angiogenesis in hepatocellular carcinoma. Oncology Reports 20(8):713-719, 2008. e-Pub 2008. PMID: 18813808.
90. Liang JJ, Alrawi S, Tan D. Nomenclature, molecular genetics and clinical significance of the precursor lesions in the serrated polyp pathway of colorectal carcinoma. Int J Clin Exp Pathol 1(4):317-324, 2008. e-Pub 2008. PMID: 18787610.
91. Liang J, Alrawi S, Fuller G, Tan D. Presacral Carcinoid Tumors Arising in Tailgut Cysts May Be Associated with Estrogen Receptor Status: Case Report and Review of the Literature. Int J Clin Exp Pathol 1(6):539-543, 2008. e-Pub 2008. PMID: 18787681.
92. Javle MM, Gibbs JF, Iwata KK, Pak Y, Rutledge P, Yu J, Black JD, Tan D, Khoury T. Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer. Ann Surg Oncol 14(12):3527-3533, 2007. e-Pub 2007.
93. Ailawadhi S, Nagase K, Jihnhee Y, Tan D, Black J, Brattain M, Javle M. Intestinal trefoil factor (TFF-3) and extracellular signal-regulated kinase (ERK) in cholangiocarcinoma. Hepato-Gastroenterology 54:1339-44, 2007. e-Pub 2007.
94. Tan D. Morphoproteomics: A Novel Approach of Protein Profiling for Identifying Potential Therapeutic Targets in Cancer Patients. Int J Clin Exp Pathol 1(4):331-332;2007, 2007. e-Pub 2007.
95. Brown RE, Tan D, Taylor JS, Miller M, Prichard JW, Kott MM. Morphoproteomic confirmation of constitutively activated mTOR, ERK, and NF-kappaB pathways in high risk neuro-blastoma, with cell cycle and protein analyte correlates. Ann Clin Lab Sci 37(2):141-7, 2007. e-Pub 2007. PMID: 17522369.
96. Loewen G, Natarajan N, Tan D, Nava E, Klippenstein D, Mahoney M, Cummings M, Reid M. Autofluorescence Bronchoscopy for Lung Cancer Surveillance Based on Risk Assessment. Thorax 62(4):335-40, 2007. e-Pub 2007.
97. Nwogu C, Fischer G, Tan D, Glinianski M, Lamonica D, Demmy T. Radioguided detection of lymph node metastasis in non-small cell lung cancer. Ann Thorac Surg 82(5):1815-20; discussion 1820, 2006. e-Pub 2006. PMID: 17062254.
98. Alrawi SJ, Carroll RE, Hill HC, Gibbs JF, Tan D, Brenner BM, Nowak NJ, Swede H, Stoler DL, Anderson GR. Genomic instability of human aberrant crypt foci measured by inter-(simple sequence repeat) PCR and array-CGH. Mutat Res 601(1-2):30-8, 2006. e-Pub 2006. PMID: 16806294.
99. Yao JL, Madeb R, Bourne P, Lei J, Yang X, Tickoo S, Liu Z, Tan D, Cheng L, Hatem F, Huang J, Anthony di Sant'Agnese P. Small cell carcinoma of the prostate: an immunohistochemical study. Am J Surg Pathol 30(6):705-12, 2006. e-Pub 2006. PMID: 16723847.
100. Alrawi S, Stoler D, Tan D, Dayton M, Loree T, Gibbs J, Rigual N, Sait S, Khoury T, Hicks W, Anderson G. Genomic Instability, DNA Alterations and Tumor Eosinophilic Expression in Head and Neck Squamous Cell Carcinoma. Cancer Genomics & Proteomics 2:307-16, 2006. e-Pub 2006.
101. Ramnath N, Tan D, Li Q, Hylander B, Hyland A, Ryes L, Ferrone S. Is Downregulation of MHC Class I Antigen Expression In Human Non-Small Cell Lung Cancer Associated With Prolonged Survival?. Cancer Immunology & Therapeutics 55(8):891-9, 2006. e-Pub 2006.
102. Oureshi KM, Raman AK, Tan D, Fakih MG. Leukemoid reaction in pancreatic cancer: a case report and review of the literature. Journal of Pancreas 7(6):631-4, 2006. e-Pub 2006.
103. Chadha K, Black J, Khoury T, Yu J, Gibbs JF, Iyer RV, Tan D, Brattain MG, Javle MM. Activated AKt and Erk Expression and Survival after Surgery in Pancreatic Carcinoma. Ann Surg Oncol 13(7):933-39, 2006. e-Pub 2006.
104. Mojica P, Rigual N, Tan D. Metastatic Adenocarcinoma of the Rectum to the Mandible; A Case Report. Journal of Oral and Maxillofacial Surgery 64(9):1436-9, 2006. e-Pub 2006.
105. Yang J, Ramnath N, Moysich KB, Asch HL, Swede H, Alrawi SJ, Huberman J, Geradts J, Brooks JS, Tan D. Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer. BMC Cancer 6:203-8, 2006. e-Pub 2006.
106. Alrawi SJ, Schiff M, Carroll R, Dayton M, Gibbs JF, Stoler DL, Tan D, Berman K, Anderson GR. Aberrant Crypt Foci. Anticancer Research 26:7-19, 2006. e-Pub 2006.
107. Alrawi SJ, Carroll R, Dayton M, Gibbs JF, Stoler DL, Tan D, Berman K, Anderson GR. Aberrant Crypt Foci(ACF) and genomic instability. Mutation Research 61:30-8, 2006. e-Pub 2006.
108. Yao J, Madeb R, Bourne P, Lei J, Yang X, Tickoo S, Liu Z, Tan D, Cheng L, Hatem F, Huang J, di Sant’Agnese A. Small Cell Prostate Carcinoma: An Immunohistochemical Study. American Journal of Surgical Pathology 30(6):705-12, 2006. e-Pub 2006.
109. Nwogu C, Fischer G, Tan D, Glinianski M, Lamonica D, Demmy T. Radioguided Detection of Lymph Node Metastasis In Non-Small Cell Lung Cancer(Radioguided Lymph Node Staging). Ann Thorac Surg 82(5):1815-20, 2006. e-Pub 2006.
110. Khoury K, Tan D, Wang J, Intengan M, Yang J, Alrawi S, Yan P, Byrd JC. : Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma. BMC Clinical Pathology 6:1-7, 2006. e-Pub 2006.
111. Mojica P, Sullivan M, Loree T, Tan D, Hicks W, Rigual N. Malignant hypercalcemia associated with a parathyroid macrocyst and the early genesis of a giant cell tumor. American Journal of Otolaryngology 27(1):54-7, 2006. e-Pub 2006.
112. Ling X, Yang J, Tan D, Ramnath N, Younis T, Bundy BN, Slocum HK, Yang L, Zhou M, Li F. Differential expression of survivin-2B and survivin-DeltaEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC). Lung Cancer 49(3):353-61, 2005. e-Pub 2005. PMID: 15936846.
113. Khoury T, Hurd T, Tan D. Phyllodes tumor with pseudoangiomatous stroma hyperplasia. Breast J 11(4):285-7, 2005. e-Pub 2005. PMID: 15982399.
114. Ramnath N, Sommers E, Robinson L, Nwogu C, Tan D, Sharma A, Cantor A, Lawrence D, Simon G, Bepler G. Phase II study of neoadjuvant chemotherapy with gemcitabine and vinorelbine in resectable non-small-cell lung cancer (NSCLC). J Clin Oncol 23(16_suppl):7277, 2005. e-Pub 2005.
115. Alrawi SJ, Tan D, Stoler DL, Dayton M, Anderson GR, Mojica P, Douglas W, Hicks W, Rigual N, Loree T. Tissue eosinophilic infiltration: a useful marker for assessing stromal invasion, survival and locoregional recurrence in head and neck squamous neoplasia. Cancer J 11(3):217-25, 2005. e-Pub 2005. PMID: 16053665.
116. Okada H, Kimura MT, Tan D, Fujiwara K, Igarashi J, Makuuchi M, Hui AM, Tsurumaru M, Nagase H. Frequent trefoil factor 3 (TFF3) overexpression and promoter hypomethylation in mouse and human hepatocellular carcinomas. Int J Oncol 26(2):369-77, 2005. e-Pub 2005. PMID: 15645121.
117. Said M, Wiseman S, Yang J, Alrawi S, Douglas W, Cheney R, Hicks W, Rigual N, Loree T, Spiegel G, Tan D. Tissue eosinophilia: a morphologic marker for assessing stromal invasion in laryngeal squamous neoplasms. BMC Clin Pathol 5(1):1, 2005. e-Pub 2005. PMID: 15638930.
118. Loewen GM, Tracy E, Blanchard F, Tan D, Yu J, Raza S, Matsui S, Baumann H. Transformation of human bronchial epithelial cells alters responsiveness to inflammatory cytokines. BMC Cancer 5:145, 2005. e-Pub 2005. PMID: 16271139.
119. Zaid M, Wiseman S, Yang J, Hicks W, Loree T, Rigual N, Spiegel G, Tan D. Tumor-associated tissue eosinophils as a predictive marker for stromal invasion of head and neck squamous cell cancer. BMC Clinical Pathology 7(5):1-7, 2005. e-Pub 2005.
120. Li F, Yang J, Ramnath N, Javle M, Tan D. Nuclear and/or cytoplasmic expression of survivin: What is the significance?. International Journal of Cancer 114(4):509-12, 2005. e-Pub 2005.
121. Alrawi SJ, Tan D, Sullivan M, Winston J, Loree TR, Hicks W, Rigual N. Peripheral Primitive Neuroectodermal Tumor of the Mandible with Cytogenetic and Molecular Biology Aberrations. Journal of Oral and Maxillofacial Surgery 63(8):1216-21, 2005. e-Pub 2005.
122. Tawk R, Tan D, Fenstermaster D. Melanotic Schwannoma with Drop Metastases to the Caudal Spine and High Expression of CD 117 (c-kit). Journal of Neuro-Oncology 71(2):151-6, 2005. e-Pub 2005.
123. Khoury T, Hurd T, Tan D. Phyllodes tumor with pseduoangiomatoid stromal hyperplasia. The Breast Journal 11(4):285-7, 2005. e-Pub 2005.
124. Ling X, Wu J, Tan D, Ramnath N, Younis T, Bundy B, Slocum H, Yang L, Zhu M, Slocum H, Li F. Differential expression of survivin and its variants is inversely associated with disease relapse and patient survival in non-small cell lung cancer (NSCLC). Lung Cancer 49(3):353-61, 2005. e-Pub 2005.
125. Alrawi SJ, Stoler D, Tan D, Dayton M, Loree T, Rigual N, Bartos J, Khoury T, Nowak N, Anderson G. Genomic Instability, DNA Alterations and Tumor Eosinophilic Expression in Head and Neck Squamous Cell Carcinoma. Cancer Genomics & Proteomics 2:307-16, 2005. e-Pub 2005.
126. Okada H, Tan D, Kimura MT, Igarashi J, Masahiko. Frequent trefoil factor 3(TFF3) overexpression and promoter hypomethylation in mouse and human hepatocellular carcinogenesis. International Journal of Oncology 26:369-77, 2005. e-Pub 2005.
127. Nwogu C, Tan D, McLean M. Diagnostic Dilemma: persistent superior mediastinal mass following treatment of Hodgkin’s Lymphoma. Case Reports and Clinical Practice Review 6:128-130, 2005. e-Pub 2005.
128. Khoury T, Chadha K, Javle M, Donohue K, LeVea C, Iyer R, Okada H, Nagase H, Tan D. Expression of intestinal trefoil factor (TFF-3) in hepatocellular carcinoma. International Journal of Gastrointestinal Cancer 35(3):171-7, 2005. e-Pub 2005.
129. Loewen G, Tracy E, Tan D, Yu J, Glenn S, Matsui S, Hawthorn L, Gaumann H. Transformation of human bronchial epithelial cells is associated with altered responsiveness to inflammatory cytokines. BMC Cancer 5:145-51, 2005. e-Pub 2005.
130. Alrawi S, Winston J, Tan D, Loree TR, Gibbs J, Hicks W, Rigual N, Lorè JM. Primary Adenocarcinoma of Cervical Esophagus. J Exp Clin Cancer Res 24(2):325-30, 2005. e-Pub 2005.
131. Alrawi S, Tan D, Stoler D, Dayton M, Anderson G, Mojica P, Douglas W, Hicks W, Rigual N, Loree T. Tissue eosinophilic infiltratinion: a useful marker for assessing stromal invasion, survival and locoregional recurrence in head and neck squamous neoplasia. Cancer Journal 11(3):217-25, 2005. e-Pub 2005.
132. Wiseman S, Tan D, Hill H. The double pylorus: an unusual endoscopic finding. Endoscopy 37(3):277, 2005. e-Pub 2005.
133. Tan D, Hou M, Lee SO, Lou W, Wang J, Trump DL, Gao AC. Interleukin-6 polymorphism is associated with more aggressive prostate cancer. Journal of Urology 174(2):753-6, 2005. e-Pub 2005.
134. Tan D, Kraybill W, Cheney R, Khoury T. Retiform hemangioendothelioma: a case report and review of the literature. J Cutan Pathol 32(9):634-7, 2005. e-Pub 2005.
135. Nwogu CM, Hill H, Tan D, Demmy T, Takita H, MD, Anderson T. Surgical Outcomes of Solitary Fibrous Tumors of the Pleura. Clinical Pulmonary Medicine 12:42-45, 2005. e-Pub 2005.
136. Khoury T, Bolos L, McGrath B, Wang M, Cheney R, Tan D. Malignant glomus tumor, a case report and review of literature, focusing on its clinicopathologic features and immunohistochemical profile. American Journal of Dermatopathology 27(5):428-31, 2005. e-Pub 2005.
137. Hawthorn L, Stein L, Varma R, Wiseman S, Loree T, Tan D. TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma. Head Neck 26(12):1069-83, 2004. e-Pub 2004. PMID: 15515157.
138. Javle MM, Tan D, Yu J, LeVea CM, Li F, Kuvshinoff BW, Gibbs JF. Nuclear survivin expression predicts poor outcome in cholangiocarcinoma. Hepatogastroenterology 51(60):1653-7, 2004. e-Pub 2004. PMID: 15532797.
139. Aljada IS, Ramnath N, Donohue K, Harvey S, Brooks JJ, Wiseman SM, Khoury T, Loewen G, Slocum HK, Anderson TM, Bepler G, Tan D. Upregulation of the tissue inhibitor of metalloproteinase-1 protein is associated with progression of human non-small-cell lung cancer. J Clin Oncol 22(16):3218-29, 2004. e-Pub 2004. PMID: 15249585.
140. Wiseman SM, Rigual NR, Hicks WL, Popat SR, Lore JM, Douglas WG, Jacobson MJ, Tan D, Loree TR. Parathyroid carcinoma: a multicenter review of clinicopathologic features and treatment outcomes. Ear Nose Throat J 83(7):491-4, 2004. e-Pub 2004. PMID: 15372923.
141. Alrawi SJ, Deeb G, Cheney R, Wallace P, Loree T, Rigual N, Hicks W, Tan D. Lipomatous hemangiopericytoma of the head and neck: immunohistochemical and DNA ploidy analyses. Head Neck 26(6):544-9, 2004. e-Pub 2004. PMID: 15162357.
142. Deeb G, Wang J, Ramnath N, Slocum HK, Wiseman S, Beck A, Tan D. Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry. Mod Pathol 17(4):430-9, 2004. e-Pub 2004. PMID: 14739904.
143. Khoury T, Lele S, Tan D. Pathologic quiz case: an asymptomatic 79-year-old woman with an abnormal Papanicolaou test. Adenoid basal carcinoma of the cervix. Arch Pathol Lab Med 128(4):485-6, 2004. e-Pub 2004. PMID: 15043480.
144. Tan D, Wiseman S, Zhou Y, Li Q, Ward P, Slocum HK, Alrawi S, Loree T, Hicks W, Rigual N, Anderson G, Stoler D. Definition of a region of loss of heterozygosity at chromosome 11q23.3-25 in head and neck squamous cell carcinoma using laser capture microdissection technique. Diagn Mol Pathol 13(1):33-40, 2004. e-Pub 2004. PMID: 15163007.
145. Bateman NW, Tan D, Pestell RG, Black JD, Black AR. Intestinal tumor progression is associated with altered function of KLF5. J Biol Chem 279(13):12093-101, 2004. e-Pub 2004. PMID: 14726538.
146. Hawthorn L, Varma S, Wiseman S, Loree T, Tan D. TMP1 and SERPIN-A Overexpression and TFF3 and CRABP1Underexpression as Biomarkers for Papillary Thyroid Carcinoma: A cDNA Microarray Study. Head and Neck 26(12):1069-1083, 2004. e-Pub 2004.
147. Deeb G, Wang J, Slocum H, Wiseman S, Ramnath N, Tan D. Altered E-cadherin (E-cad) and epidermal growth factor receptor (EGFR) expressions affect patient survival in non-small cell lung cancer (NSCLC). Modern Pathology 17(4):430-39, 2004. e-Pub 2004.
148. Collins Y, Tan D, Pejovic T, Mor G, Qian F, Rutherford T, Varma R, McQuaid D, Driscoll D, Jiang M, Deeb G, Lele S, Nowak N, Odunsi K. Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarray. Int Journal of Molecular Medicine 14(1):43-53, 2004. e-Pub 2004.
149. Alrawi SJ, Deeb G, Loree T, Cheney R, Gallance P, Tan D. Immunohistochemistry and DNA ploidy analyses of lipomatous hemangiopericytoma. Head and Neck 26(6):544-9, 2004. e-Pub 2004.
150. Douglas W, Tracy E, Tan D, Yu J, Hicks W, Rigual N, Loree T, Wang Y, Baumann H. Development of head and neck squamous cell carcinoma is associated with altered cytokine responsiveness. Molecular Cancer Research 6:585-593, 2004. e-Pub 2004.
151. Aljada I, Ramnath N, Donahue K, Harvey S, Brooks J, Wiseman S, Slocum H, Loewen G, Thaer K, Anderson T, Bepler G, Tan D. Up-regulation of the tissue inhibitor of matrix metalloproteinase-1(TIMP-1) protein is associated with tumor progression of human non-small cell lung cancer. Journal of Clinical Oncology 22(16):3218-3229, 2004. e-Pub 2004.
152. Javle M, Tan D, Yu J, LeVea C, Li F, Kuvshinoff B, Gibbs J. Nuclear survivin expression predicts poor prognosis in cholangiocarcinoma. Hepatogastroenterology 51:1653-57, 2004. e-Pub 2004.
153. Chu Q, Hurd T, Harvey S, Martinick M, Markus G, Tan D, Gibbs J, Loree T. Overexpression of Urinary Plasminogen Activator (uPA) Protein and mRNA in Thyroid Carcinogenesis. Diagnostic Molecular Pathology 13(4):241-246, 2004. e-Pub 2004.
154. Yang J, Tan D, Asch H, Swede H, Kirsten M. Prognostic significance of gelsolin expression level and variability in non-small cell lung cancer. Lung Cancer 46(1):29-42, 2004. e-Pub 2004.
155. Tan D, Wiseman S, Zhou Y, Li Q, Ward P, Malik D, Rigual N, Hicks W, Loree T, Anderson G, Stoler D. Definition of loss of heterozygosity at telometic 11q in oncogenesis of head and neck squamous cell carcinoma. Diagnostic Molecular Pathology 13(1):33-40, 2004. e-Pub 2004.
156. Hernandez F, Tan D, Connolly G, Ramnath N. Multimodality therapy for thymic carcinoma (TCA): results of a 30-year single-institution experience. Am. J. Clin. Oncol 27(1):68-72, 2004. e-Pub 2004.
157. Bateman NW, Tan D, Pestell RG, Black JD, Black AR. Colon tumor progression is associated with altered function of KLF5. J Biochem Chem 279(13):12093-12101, 2004. e-Pub 2004.
158. Loewen GM, Krauza M, Hyland A, Deeb G, Tan D. Detection of Epithelial Metaplasia and Dysplasia with Autofluorescence Bronchoscopy. Cancer Detection and Prevention 14(10):1102-8, 2004. e-Pub 2004.
159. Loewen G, Reid M, Tan D, Klippenstein D, Grossman Z, Nava E, Hyland A, Raza S, Cummings M, Natarajan R, Mahoney M. Bimodality lung cancer screening in high- risk patients: a preliminary report. Chest 125(5):163S-4S, 2004. e-Pub 2004.
160. Wiseman W, Chu Q, Hicks W, Rigual N, Popat S, Lore J, Douglas W, Tan D, Loree T. Parathyroid Carcinoma: A Multicenter Report of Clinicopathologic Characteristics and Treatment Outcomes. Ear, Nose & Throat Journal 83(7):491-494, 2004. e-Pub 2004.
161. Koury T, Lele S, Tan D. Adenoid Basal Carcinoma of Uterine Cervix. Archives of Pathol & Lab Medicine 128(4):485-6, 2004. e-Pub 2004.
162. Tan D, Deeb G, Wang J, Slocum HK, Winston J, Wiseman S, Beck A, Sait S, Anderson T, Nwogu C, Ramnath N, Loewen G. HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization. Diagn Mol Pathol 12(4):201-11, 2003. e-Pub 2003. PMID: 14639106.
163. Jiang M, Anderson T, Nwogu C, Tan D. Pulmonary malignant granular cell tumor. World J Surg Oncol 1(1):22, 2003. e-Pub 2003. PMID: 14613555.
164. Harvey SR, Hurd TC, Markus G, Martinick MI, Penetrante RM, Tan D, Venkataraman P, DeSouza N, Sait SN, Driscoll DL, Gibbs JF. Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer. Clin Cancer Res 9(13):4935-43, 2003. e-Pub 2003. PMID: 14581368.
165. Wiseman SM, Swede H, Stoler DL, Anderson GR, Rigual NR, Hicks WL, Douglas WG, Tan D, Loree TR. Squamous cell carcinoma of the head and neck in nonsmokers and nondrinkers: an analysis of clinicopathologic characteristics and treatment outcomes. Ann Surg Oncol 10(5):551-7, 2003. e-Pub 2003. PMID: 12794022.
166. Tan D, Li Q, Deeb G, Ramnath N, Slocum HK, Brooks J, Cheney R, Wiseman S, Anderson T, Loewen G. Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study. Hum Pathol 34(6):597-604, 2003. e-Pub 2003. PMID: 12827614.
167. Tan D, Kirley S, Li Q, Ramnath N, Slocum HK, Brooks JS, Wu CL, Zukerberg LR. Loss of cables protein expression in human non-small cell lung cancer: a tissue microarray study. Hum Pathol 34(2):143-9, 2003. e-Pub 2003. PMID: 12612882.
168. Ming J, Anderson T, Nwogu CM, Tan D. Pulmonary Malignant Granular Cell Tumor. A case report and literature review. World Journal of Surgical Oncology 1:22-25, 2003. e-Pub 2003.
169. Tan D, Kirley S, Li Q, Ramnath N, Slocum H, Brooks S, Wu C, and Zukerberg L. Loss of Cables Protein Expression in Human Non-Small Cell Lung Cancer. Human Pathol 34(2):143-149, 2003. e-Pub 2003.
170. Zhao X, Deeb G, Tan D. Cystic hypersecretory hyperplasia with atypia of the breast. Archives of Pathol & Lab Medicine 127(9):389-391, 2003. e-Pub 2003.
171. Wiseman S, Swede H, Stoler DL, Anderson G, Rigual N, Hicks W, Tan D, Loree T. Squamous cell carcinoma of the head and neck in non-smokers and non-drinkers: An analysis of clinicopathologic factors and treatment outcomes. Annuals of Surgical Oncology 10(5):551-557, 2003. e-Pub 2003.
172. Anderson TM, Dougherty TJ, Tan D, Sumlin A, Schlossin J, Kanter P. Photodynamic therapy for sarcoma pulmonary metastases: A preclinical toxicity study. Anticancer Res 23(5):3713-3718, 2003. e-Pub 2003.
173. Tan D, Deeb G, Wang J, Slocum H, Winston J, Wiseman S, Beck A, Sait S, Anderson T, Nwogu C, Ramnath N, Loewen G. HER-2/neu protein expression and gene alteration in stage I-IIIA non-small cell lung cancer: A study of 140 cases utilizing a combination of high throughput tissue microarray, immunohistochemistry and fluorescent in-situ hybridization. Diagnostic Molecular Pathology 12:223-235, 2003. e-Pub 2003.
174. Harvey SR, Markus G, Martinick MI, Penetrante R, Tan D, Venkataraman P, DeSouza N, Sait S, Driscoll D, Hurd T, Gibbs J. Evaluation of urinary plasminogen activator (uPA), its receptor (uPAR), matrixmetalloproteinase-9 (MMP-9), and von Willebrand Factor in pancreatic cancer. Clinical Cancer Research 9:4935-4943, 2003. e-Pub 2003.
175. Tan D, Li Q, Deeb G, Ramnath N, Slocum H, Cheney R, Anderson T, Brooks J, Wiseman S, Loewen G. Thyroid Transcription Factor-1(TTF-1) Expression Prevalence and Its Clinical Implications in Non-Small-Cell Lung Cancer: A High-Throughput Tissue Microarray and Immunohistochemistry Study. Human Pathol 34(6):597-604, 2003. e-Pub 2003.
176. Tan D, Li Q, Ramnath N, Beck A, Wiseman S, Al Salameh A, Brooks J, Bepler G, Anderson T. Prognostic relevance of the expression of p53 oncoprotein in non-small cell lung cancer. Anticancer Research 23(3):1665-1672, 2002. e-Pub 2002.
177. Zhu W, Beck AF, Zou H, Chervinsky D, Brooks J, Tan D. Loss of heterozygosity in primary lung cancer using laser capture microdissection and wave DNA fragment analysis techniques. Med Sci. Monit 8:95-99, 2002. e-Pub 2002.
178. Wiseman SM, Loree TR, Hicks W, Rigual N, Winston J, Tan D, Anderson G, Stoler D. Anaplastic thyroid cancer evolved from papillary carcinoma: demonstration of anaplastic transformation utilizing the inter-simple sequence repeat polymerase chain reaction. Arch Otolaryngol Head Neck Surg 129:96-100, 2002. e-Pub 2002.
179. Tan D, Huberman JA, Hyland A, et al. Mcm2-BM8: A novel diagnostic marker for early detection of premalignant squamous epithelial lesions. BMC Cancer 11:1-6, 2001. e-Pub 2001.
180. Ramnath R, Hernandez FJ, Tan D, Huberman J, Nataraan N, Beck A, Hyland A, Todorov I, Brooks J, Belper G. MCM2 is an independent predictor of survival in patients with non small cell carcinoma. Journal of Clinical Oncology 19:4257-4266, 2000. e-Pub 2000.

Review Articles

1. Luo W, Hofstetter WL, Tan D. Gastroesophageal junction Paneth cell carcinoma with extensive cystic and secretory features - case report and literature review. Diagn Pathol 14(1):1, 2019. e-Pub 2019. PMID: 30621725.
2. Luo W, Fedda F, Lynch P, Tan D. CDH1 Gene and Hereditary Diffuse Gastric Cancer Syndrome: Molecular and Histological Alterations and Implications for Diagnosis And Treatment. Front Pharmacol 9:1421, 2018. e-Pub 2018. PMID: 30568591.
3. Mojica-Manosa P, Rigual N, Tan D, Sullivan M. An unusual case of a metastatic adenocarcinoma of the rectum to the mandible: a case report and review of the literature. J Oral Maxillofac Surg 64(9):1436-9, 2006. e-Pub 2006. PMID: 16916682.
4. Li F, Yang J, Ramnath N, Javle MM, Tan D. Nuclear or cytoplasmic expression of survivin: what is the significance?. Int J Cancer 114(4):509-12, 2005. e-Pub 2005. PMID: 15578717.

Professional Educational Materials

1. Abraham S, Maru D, Rashid A, Tan D, Wang H. GI surgical pathology gross manual, 2009.

Other Articles

1. Tan D, Yesner R, Zou H Differential diagnosis of diffuse pelvic mesothelioma by immunohistochemistry and electronic microscopy: Analysis of 23 cases, 1995.
2. Tan D, Mansfield B The role of mast cell in histogenesis of asbestosis. Essen Medicine, 1991.
3. Tan D, Wu Z Preliminary observation of the aflatoxin-induced liver neoplasms. Tongji Med. Acta, 1990.

Abstracts

1. Zhang, JP, Yin, ZC, Tan, D. Role of Electronic Microscopy in Evaluation of Hereditary Hyperbilirubinaemia - A Clinicopathological Correlation Study of 24 Cases. Mod Pathol 30(S2):537A-538A, 2017. e-Pub 2017.
2. Sharma M, Lalonde A, Tan D, Wu T, Zhou Z. Expression of Epithelial-Mesenchymal Transition Markers E-Cadherin and Vimentin in Esophageal Adenocarcinoma and Squamous Cell Carcinoma and Significant Association with New Proliferation Markers MCM4 and MCM7. Mod Pathol 30(S2):201A, 2017. e-Pub 2017.
3. Yin, ZC, Zhang, JP, Zhou, ZR, Tan, D. Diagnostic Utilities of Electronic Microscopy(EM) in Genetic and Metabolic Liver Diseases - A Study of 105 Cases in Chinese Population. Mod Pathol 30(S2):427A-427A, 2017. e-Pub 2017.
4. Kim SJ, Hsu C, Song YQ, Tay K, Hong XN, Cao J, Kim JS, Eom HS, Lee JH, Zhu J, Chang KM, Reksodiputro AH, Tan D, Goh YT, Lee J, Intragumtornchai T, Chng WJ, Cheng AL, Lim ST, Suh C, Kwong YL, Kim WS. Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group. Eur J Cancer 16(49):3486-3496, 2013. e-Pub 2013.
5. Ridtitid W, Tan D, Schmidt SE, Fogel EL, McHenry L, Watkins JL, Lehman GA, Sherman S, Cote GA. Endoscopic papillectomy:rick factors for incomplete resection and recurrence during long-term-follow-up. Gasrtointest Endosc 13, 2013. e-Pub 2013.
6. Zhai Q, Yan L, Tan D, Chen R, Sun J, Gao L, Dong MQ, Wang Y, Li C. Phosphorylation-coupled proteolysis of the transcription factor MYC2 is important for jasmonate-signaled plant immunity. PloS Genet 4(9), 2013. e-Pub 2013.
7. Chen WC, Maru DM, Abraham SC, Tan D, Raju GS. Endoscopic clip tamponade of bleeding: a novel adjunct technique for endoscopic mucosal resection. Endoscopy, 2013. e-Pub 2013.
8. Tan D, Zhou Z. Amplification of the Genes on Chromosome 19q13.3 Represents the Signature Molecular Event Predicting the Clinical Outcome of Gastric Adenocarcinoma. Mod Pathol 26:182A, 2013. e-Pub 2013.
9. Ridtitid W, Tan D, Scmidt SE, Fogel EL, McHenry L, Watkins JL, Lehman GA, Sherman S, Cote GA. Endoscopic papillectomy: risk factors for incomplete resection and recurrence during long-term follow-up. Gastrointest Endodc 13(s0016-5107), 2013. e-Pub 2013.
10. Khoury T, Tan D, Bshara W. HER2 testing: The equivocal category by immunohistochemistry should be expanded to include cases with any 2+ staining cases with 3+ staining in <70% instead of <30% of tumor cells to have high concordance rate with FISH. Mod Pathol 24:48A, 2011. e-Pub 2011.
11. Khoury T, Foluso A, Chandraseekhar R, Gregory W, DeLeo A, Ferrone S, Wang S, Monhollen L, Tan D, Wang X. Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase-1A1 Expression with Poor Prognosis in the Conventional Neoadjuvant Chemotherapy. Mod Pathol 24:49A, 2011. e-Pub 2011.
12. Tan D, Payne W, Khoury T, Li W, Bhadkamkar N, Javle M. Osteoclastic giant cell tumor of the pancreas: Clinicopathological correlation study of twelve cases. Mod Pathol 24:170A, 2011. e-Pub 2011.
13. Liu W, Zakharia Y, Tan W, Wilding G, Edge S, Tan D, Khoury T. Intraoperative Detection of Sentinel Lymph Node Metastases from Breast Cancer: Does the Pathologist Experience, Subspecialty or the Surgeon Experience Matter?. Modern Pathology 23(1):59A, 2010. e-Pub 2010.
14. Hu Y, Hicks D, Godfrey T, Peters J, Tan D, Qiu X, Zhou Z. Endometrial Adenosarcomas: Diagnostic Use of Ki-67 Proliferation HER-2/Neu Overexpression and Amplification in Esophageal Adenocarcinoma and High Grade Dysplasia. Modern Pathology 23(1):148A, 2010. e-Pub 2010.
15. Zhang S, Zakharia Y, Tan W, Wilding G, Edge S, Liu W, Tan D, Khoury T. Breast Hormonal Receptors Test Should Be Repeated on Excisional Biopsies after Negative Core Biopsy. Modern Pathology 23(1):80A, 2010. e-Pub 2010.
16. Li W, Tan D, Zhang P. Expression of Ezrin in Neoplastic and Nonneoplastic Liver Lesions. Modern Pathology 23(1):362A, 2010. e-Pub 2010.
17. Feng W, Zhou Z, Tan D. Expression of S100p in Human Esophageal Adenocarcinoma and Its Precursor Lesions. Modern Pathology 23(1):144A, 2010. e-Pub 2010.
18. Dhingra S, Feng W, Zhou D, Khoury T, Brown RE, Tan D. Expression of Stem Cell Markers in Human Gastric Adenocarcinoma and Non-Neoplastic Gastric Mucosa, a Study of 209 Cases. Modern Pathology 23(1):143A, 2010. e-Pub 2010.
19. Feng W, Zhou Z, Tan D. Stem Cell Markers CD44 and Nestin in Human Esophageal Adenocarcinoma and Its Precursor Lesions. Modern Pathology 23(1):145A, 2010. e-Pub 2010.
20. Liu WG, Al-Agha OM, Chandrasekhar R, Wilding G, Tan DF, Alrawi S, Khoury T. CD138 (Syndecan-1) in Thymic Neoplasms: Correlation with Various World Health Organization Types and Clinical Outcome. Modern Pathology 23(1):408A, 2010. e-Pub 2010.
21. Li W, Tan D, Zhang P. Significance of S100A4 in Angiogenesis of Hepatocellular Carcinoma. Modern Pathology 23(1):361A, 2010. e-Pub 2010.
22. Khoury T, Malik D, Fan C, Tan D, Kulkartni S. "Modified" Alcian Blue Enhances the Intraoperative Diagnosis of Sentinel Lymph Node Metastasis in Invasive Lobular Carcinoma: A Prospective Study. Arch pathol clin med 134(10):1513-9, 2010. e-Pub 2010.
23. Khoury T, Zakharia Y, Hwang H, Liu W, Edge S, Tan D, Morrison C. HER2 Testing: How To Get High Concordance Rate between Immunohistochemistry and Fluorescence In Situ Hybridization. Modern Pathology 23(1):56A, 2010. e-Pub 2010.
24. Kanehira K, Zakharia Y, Tan W, Liu W, Wilding G, Edge S, Tan D, Khoury T. Frozen Section Versus Touch Preparation for Intraoperative Detection of Sentinel Lymph Node Metastases from Breast Cancer: A Single Institution Experience of 396 Cases. Modern Pathology 23(1):54A, 2010. e-Pub 2010.
25. Truong CD, Ylip A, Feng W, Li W, Khoury T, Yao J, Xie K, Zhang W, Tan D. Prognosis of Gastric Cancer: A Genome-Wide Study Using 244K Array Comparative Genomic Hybridization (aCGH) and Verification by Fluorescent In-Situ Hybridization (FISH). Mod Pathol 22(1), 2009. e-Pub 2009.
26. Xu B, Tan D, Thong T, Khoury T. Positive Immunoreactivity of Thyroid Transcription Factor-1 in Colorectal Carcinoma: A Tissue Microarray Study of 104 Cases. College of American Pathologists, Washington, DC, 2009. e-Pub 2009.
27. Feng W, Truong CD, Brown RE, Duan X, Li W, Xiao J, Xie K, Tan D. Up-Regulation of REG Is Associated with Human Gastric Adenocarcinoma: A Study of 216 Cases. Mod Pathol 22(1), 2009. e-Pub 2009.
28. Feng W, Truong CD, Zhai J, Zhou Z, Tan D. Expression of Insulin-Like Growth Factor II mRNA-Binding Protein 3 (IMP3) in Human Esophageal Adenocarcinoma and Its Precursor Lesions. Mod Pathol 22(1), 2009. e-Pub 2009.
29. Khoury, Wilding G, Chandrasekhar R, Alrawi S, Tan D. A Panel of Immunohistochemistry To Differentiate Various WHO Types of Thymic Neoplasms. Mod Pathol 22(1), 2009. e-Pub 2009.
30. Fan C, Malik D, Kulkartni S, Daoud N, Tan D, Khoury T. Modified Alcian Blue Enhances the Intraoperative Diagnosis of Sentinel Lymph Node Metastasis in Invasive Lobular Carcinoma: A Prospective Study. Mod Pathol 22(1), 2009. e-Pub 2009.
31. Truong CD, Feng W, Li W, Khoury T, Alrawi S, Yao J, Xie K, Rossi S, Calin G, Tan D. MiRNA-21, a Potential Prognostic Marker for Human Gastric Cancer. Mod Pathol 22(1), 2009. e-Pub 2009.
32. Truong CD, Feng W, Li W, Khoury T, Yao J, Xie K, Tan D. Assessing HER-2/Neu Protein Expression and Gene Alteration in Gastric Cancer: Comparing Arrayed Comparative Genomic Hybridization (aCGH) Technique with Immunohistochemistry (IHC) and Fluorescent In-Situ Hybridization (FISH). Mod Pathol 22(1), 2009. e-Pub 2009.
33. Khoury T, Arshad A, Arnouk M, Alrawi S, Tan D. Thymoma: Immunohistochemistry Study with Emphasis on Lymphoid Markers (CD57, CD20, CD3, and CD5) and Clinicopathologic Correlation. Mod Pathol 21(1):260A, 2008. e-Pub 2008.
34. Davis DW, Zhai QJ, Li W, Tan D, Allen TC, Popper HH, Cagle PT. Expression of Alpha-Methylacyl-COA Racemase (AMACR) in Tissue Microarray of 39 Cases of Diffuse Malignant Mesothelioma (DMM). Mod Pathol 21(1):340A, 2008. e-Pub 2008.
35. Feng W, Truong CD, Li W, Khoury T, Alrawi S, Xia K, Yao J, Tan D. Thyroid Transcription Factor 1 is Not Expressed in Gastric Adenocarcinoma: A Study of 220 Cases. Mod Pathol 21(1):118A, 2008. e-Pub 2008.
36. Truong C, Li W, Feng W, Cagle P, Khoury T, Alrawi A, Xie K, Yao J, Tan D. Significance of HER-2/neu protein experssion and gene alteration in gastric cancer: A study of 208 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in-situ hybridization. AACR Annual Meeting in San Diego, CA, 2008. e-Pub 2008.
37. Feng W, Li W, Truong C, Cagle P, Khoury R, Alrawi S, Xie K, Yao J, Tan D. Morphoproteomic Profile of mTOR, Ras/Raf kinase and NF-kB pathways in human gastric adnocarinomca. AACR Annual Meeting in San Diego, CA, 2008. e-Pub 2008.
38. Taggart MW, Wang H, Maru DM, Tan D, Rashid A. Appendiceal Mixed Carcinoid-Adenocarcinomas Share Better Prognosis Associated with Goblet Cell Carcinoid Tumors. Mod Pathol 21(1):137A, 2008. e-Pub 2008.
39. Li W, Cagle P, Zhang Z, Tan D. Expression of α-Methylacyl Coenzyme A Racemase (AMACR/P504S) in Neoplastic and Nonneoplastic Liver Lesions. Mod Pathol 21(1):309A, 2008. e-Pub 2008.
40. Truong CD, Feng W, Li W, Khoury T, Alwari S, Xia K, Yao J, Tan D. Characteristics of Epstein-Barr Virus-Associated Gastric Cancer: 20-Year Experience in a Single Medical Center. Mod Pathol 21(1):138A, 2008. e-Pub 2008.
41. Truong C, Li W, Feng E, Cagle P, Khoury T, Alrawi S, Xie K, Yao J, Tan D. Expression of SOX9 and p63: A study of 200 cases to deternine their role in human gastric cancer. AACR Annual Meeting in San Diego, CA, 2008. e-Pub 2008.
42. Truong CD, Li W, Feng W, Cagle P, Khoury T, Alrawi S, Xia K, Yao J, Tan D. Alpha-Methylacyl-CoA Racemase (AMACR) is Upregulated in Gastric Cancer: A Study of 220 Cases. Mod Pathol 21(1):137A, 2008. e-Pub 2008.
43. Fang X, Liu W, Iyer R, Tan D, Arnouk M, Ambuga B, Alrawi S, Khoury T. CD56 is Useful in Differentiating Foregut Gastrointestinal Neuroendocrine Tumors from Midgut or Hindgut and WHO Grade 1 from Grade 2 or 3 Tumors. College of American Pathologists, San Diego, CA, 2008. e-Pub 2008.
44. Li W, Tan D, Zhang Z, Brown RE. The Akt Pathway in Angiogenesis of Hepatocellular Carcinoma: A Immunohistochemical Stain Based Analysis. Mod Pathol 21(1):309A, 2008. e-Pub 2008.
45. Khoury T, Arshad A, Arnouk M, Tan D. D2-40, Mesothelin, Podoplanin and Other Mesothelioma-Ralated Marker in Thymic Tumors: A Tissue Microarray Analysis of 57 Cases. Mod Pathol 21(1):344A, 2008. e-Pub 2008.
46. Kundu UR, Li W, Tan D, Allen TC, Zhai QJ, Cagle PT. Alpha-methylacyl-co-a-racemase (AMACR) Expression Is a Biomarker of Poor Prognosis in Stage 1 and 2 Large Cell Carcinomas of the Lung. Mod Pathol 21(1):345A, 2008. e-Pub 2008.
47. Brown R, Yao J, Javale M, Tan D. Constitutively Activated mTOR, ERK and NF-kappaB Pathways in Colorectal Cancer. Annals of America Society of Clinical Oncology, Chicago, IL, 2007. e-Pub 2007.
48. Seiwert T, Bracht L, Ferguson B, Janamachi V, Ramasamy J, Husain A, Padilla M, Li Q, Tan D, Papathanassiu A, Salgia R. HSP27-a significantly therapeutic target for non-small cell lung cancer. AACR Annual Meeting, Los Angels, CA, 2007. e-Pub 2007.
49. Tan D, Yao J, Javle M, Law A, Brown R. Morphoproteomic Depiction of Constitutively Activated mTOR and ERK Pathways in Adenocarcinoma of the Large Intestin: A Pilot Study. Journal of CLinical Oncology 25(18S), 2007. e-Pub 2007.
50. Malhotra RK, Li W, Cagle PT, Tan D. Immunohistochemical evaluation of expression and distribution pattern of novel vascular markers (CD105 and D2-40) in cirrhosis and hepatocellular carcinoma. 96th Annual Meeting of United States and Canadian Academy of Pathology, Modern Pathology 20(Suppl 2):1622A, 2007. e-Pub 2007.
51. Brown R, Tan D, Taylor J, Miller M, Prichard J, Kott M. Morphoproteomic Confirmation of Constitutively Activated mTOR, ERK and NF-kappaB Pathways in High Risk Neuroblastoma with Cell Cycle and Protein Analyte Correlates. 96th Annual Meeting of United States and Canadian Academy of Pathology, Modern Pathology 20(Suppl 2):1430A, 2007. e-Pub 2007.
52. Seiwert T, Bracht L, Ferguson B, Janamachi V, Ramasamy J, Husain A, Padilla M, Li Q, Tan D, Papathanassiu A, Salgia R. HSP27-a novel prognostic marker and therapeutic target for non-small cell lung cancer. AACR Annual Meeting, Washington D.C, 2006. e-Pub 2006.
53. Alrawi S, Stoler D, Carroll R, Tan D. New Parameters in Risk Stratification in Papillary Thyroid Carcinoma: Eosinophilic Infiltration Gl. ORAL PRESENTATION at SSO's 59th Annual Cancer Symposium, San Diego, CA, 2006. e-Pub 2006.
54. Gomez GM, Tan D, Zander DS, Castro CY, Sienko AG, Haque AK, Barrios RJ, Allen TC, Singhal NA, Cagle PT. Myoepithelial and Salivary Duct Differentiation Markers in Non-Small Cell Lung Cancer. Laboratory Investigation 86(1):308A, 2006. e-Pub 2006.
55. Gomez EM, Tan D, Zander DS, Haque AK, Castro CY, Allen TC, Sienko AE, Barrios RJ, Singhal NA, Cagle PT. Pulmonary Neuroendocrine Tumors Can Express Markers of Myoepithelial and Salivary Duct Differentiation. Mod Pathol 19(1):308A, 2006. e-Pub 2006.
56. Alrawi SJ, Carroll R, Dayton M, Tan D, Gibbs J, Stoler D, Anderson G. New parameters in aberrant crypt foci evaluation in colon carcinogenesis (Glutathione S-Tranferase, B-RAF mutation, Genonmic Instability, Single Nucleotide Polymorphism (SNP) arrays). Journal of Surgical Research 130:163, 2006. e-Pub 2006.
57. Tan D, Khoury T, Chadha K, Yu J, Black J, Kuvshinoff B, Brattin M, Javle M. Activated Akt and Erk Expression in Inversely Associated with Survival of Patients with Pancreatic Carcinoma. College of American Pathologist Annual Meeting, San Diego, CA, 2006. e-Pub 2006.
58. Alrawi S, Stoler D, Tan D, Wiseman S, Rigual N, Loree T, Anderson G. Glutathione S Transferase and Molecular and Clinicopathological Parameters in Papillary Thyroid Cancer. Society of Surgical Oncology, 2006. e-Pub 2006.
59. Yan P, Byrd J, Alrawi S, Khoury T, Wei L, Tent W, Flynn S, Tan D. Mucin Phenotype of Pancreatic Carcinoma and Non-Neoplastic Pancreatic Tissue: Its Diagnostic Utility in FIne Needle Aspiration (FNA) Specimens. 14th International Academic Pathology Meeting, Montreal, Canada, 2006. e-Pub 2006.
60. Khoury T, Wang J, Slocum H, Tan D. Eukaryotic Initiation Factor-4E (eIF-4E) and Cyclin D1 expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry. Mod Pathol 19(1):311A, 2006. e-Pub 2006.
61. Alrawi SJ, Stoler D, Tan D, Gibbs J, Rigual N, Wiseman S, Loree T, Anderson G. Tissue Eosinophilia, Genomic Instability and Clincopathological Parameters in Papillary Thyroid Cancer. Annals of Surgical Oncology Supp Vol 13(2):S15, 2006. e-Pub 2006.
62. Nwogu C, Fischer G, Tan D, Glinianski M, Lamonica D, Demmy T. Radioguided Detection of Lymph Node Metastasis In Non-Small Cell Lung Cancer (Radioguided Lymph Node Staging). Southern Thoracic Surgical Association, Orlando, FL, 2005. e-Pub 2005.
63. Sommers E, Ramnath N, Robinson L, Tan D, Belper G. Neoadjuvant chemotherapy with gemcitabine and vinorelbine in resectable non-small-cell lung cancer(NSCLC). Lung Cancer 49 Supplement:S96-97, 2005. e-Pub 2005.
64. Khoury T, Wang J, Tan D. Eukaryotic Initiation Factor-4E (eIF-4E) and Cyclin D1 expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry. American Association of Cancer Research, Anaheim, CA, 2005. e-Pub 2005.
65. Alrawi S, Stoler D, Tan D, Gibbs J, Anderson G. Genomic instability of aberrant crypt foci and colon cancer surveillance. The 66th Annual Meeting of Surgery, Nashville, Tennessee, 2005. e-Pub 2005.
66. Alrawi S, Stoler D, Tan D, Swede H, Wiseman S, Rigual N, Loree T, Anderson G. Tissue Eosinophia, Genomic Instability and Clinicopathological Parameters in Papillary Thyroid Cancer. Society of Surgical Oncology(24-5), 2005. e-Pub 2005.
67. Wang Y, Barbour K, Clements JL, Shrikant P, Tan D, Tracy E, Huntoon K, Lim SK, Berger FG, Baumann H. Haptoglobin, a major acute phase plasma protein in the mouse, promotes lymphopoiesis and function of the immune cells, 2005. e-Pub 2005.
68. Chadha K, Khoury T, Levea C, Nagase H, Okada H, Tan D, Javle MM. Intestinal trefoil factor expression in hepatocellular carcinoma. Proc GI American Society of Clinical Oncology(abstract 119), 2005. e-Pub 2005.
69. Foster J, Black J, Khoury T, Levea C, Tan D, Donohue K, Chadha K, Gibbs J, Javle M. COX-2 expression and activation of EGFR pathway are common in hepatocellular carcinoma. Proc GI American Society of Clinical Oncology(abstract 125), 2005. e-Pub 2005.
70. Ailawadhi S, Khoury T, Levea C, Javle M, Kuvshinoff B, Okada H, Black J, Brattain M, Tan D. Intestinal trefoil factor (TFF-3) expression and correlation with other signaling proteins in cholangiocarcinoma. Proc GI American Society of Clinical Oncology(abstract 154), 2005. e-Pub 2005.
71. Wiseman SM, Reidy J, Swede H, Loree T, Rigual N, Hicks W, Huberman J, Tan D, Winston J. MCM2: Test of Utility as a Molecular Marker in Advanced Stage Oropharyngeal Carcinoma. Proceedings of the American Society of Clinical Oncology 2004 Annual Meeting, New Orleans, Louisiana, U.S.A, 2004. e-Pub 2004.
72. Tan D, Hou M, Lee SO, Lou W, Wang J, Trump DL, Gao A. Interleukin-6 polymorphism and risk of development of advanced prostate cancer. American Society of Cancer Research Annual Meeting, Orlando, FL, 2004. e-Pub 2004.
73. Wiseman S, Zaho J, Winston J, Tan D, Stoler D, Anderson G, Rigual NR, Hicks WL, Loree TR. Immunohistochemical Expression of CA19-9 in papillary thyroid carcinoma: A potential marker for biologically aggressive disease. American Society of Cancer Research Annual Meeting, Orlando, FL, 2004. e-Pub 2004.
74. Khoury T, Intengan M, Wang J, Winston J, Tan D. MUC-1 (Ma695) Immunostain Distinguishes Between Mucinous Carcinoma of Endometrial and Endocervical Origin. Poster and oral presentation at The American Society of Clinical Pathology meeting San Antonio, TX 122:627-628, 2004. e-Pub 2004.
75. Kim M, Tan D, LeVea C, Yu J, Kuvshinoff B, Suneetha D, Gibbs J, Javle M. Nuclear survivin expression correlates with poor prognosis in cholangiocarcinoma. Annual Meeting of American Society of Clinical Cancer Research, New Orleans, LA, 2004. e-Pub 2004.
76. Alrawi S, Hicks W, Rigual N, Loree T, Tan D. Tissue Eosinophilia: A Valuable Morphologic Marker in Assessing Stromal Invasion, Locoregional Recurrence and Distant Metastasis in Head & Neck Squamous Cell Carcinoma. 93rd Annual Meeting of United States and Canadian Academy of Pathology, Modern Pathology 17(1):220A-927, 2004. e-Pub 2004.
77. Khoury T, Orozco A, Intengan M, Nava MER, Tan D. A Defined Panel of Markers (Villin, Thyroid Transcription Factor-1, CD56, and CD57) is Useful in Differentiating the Primary Site of Neuroendocrine Carcinoma. American Journal of Clinical Pathology 122(643), 2004. e-Pub 2004.
78. Martinick M, Khoury T, Tan D, Geradts J, Markus G, Gibbs J, Harvey S. Expression of a Truncated Urokinase (UK) in Disulfide Complex with Haptoglobin (Hp) and a Neural Cell Adhesion-Like Molecule (NCAM) in Human Colon Cancers. Presented at the 3rd EORTC International Meeting on Cancer Molecular Markers. April 2004-Brussels, Belgium. The International Journal of Biological Markers, 19-S3, 2004. e-Pub 2004.
79. Loewen G, Eracy M, Reid S, Natarajan RR, Tan D, Baumann H. A method for determination of the cytokine response of cultured premalignant bronchial epithelial cells. Second Annual International Conference on Frontiers in Cancer Prevention Research Conference, Phoenix, AZ, 2003. e-Pub 2003.
80. Bateman NW, Tan D, Black JD, Black AR. Altered function of KLF5 is associated with colorectal tumor progression. Digestive Disease Week, Orlando, Florida, 2003. e-Pub 2003.
81. Tan D, Wiseman S, Li Q, Slocum HK, Loree T, Hicks W, Rigual N, Stoler D, Anderson G. Definition of a Region of Loss of heterozygosity (LOH) at chromosome 11q23.3-25 in head and neck squamous cell carcinoma using laser capture microdissection technique. 92nd United States and Canadian Pathology Annual Meeting, Washington, D.C. Modern Pathology 16(1):A-1016, 2003. e-Pub 2003.
82. Tan D, Li Q, Deeb G, Slocum HK, Ramnath N, Loewen G, Wiseman S, Beck A, Anderson T, Brook JJ. A High-Density Tissue Microarray (TMA) and Immunohistochemistry (IHC) Study of Thyroid Transcription Factor-1(TTF-1) Expression in Non-Small-Cell Lung Cancer (NSCLC). 92nd United States and Canadian Pathology Annual Meeting, Washington, D.C. Modern Pathology 16(1):A-1438, 2003. e-Pub 2003.
83. Tan D, Piao YC, Li Q, Slocum HK, Younis T, Wiseman S, Brooks JJ, Li FZ, Ramnath N. Significance of Survivin Expression in Non-Small-Cell Lung Cancer(NSCLC): A Tissue Microarray Study. Modern Pathology 16(1):A-1437, 2003. e-Pub 2003.
84. Loewen G, Krauza M, Hyland A, Klippenstein D, Tan D. Detection of premalignant bronchial epithelial abnormalities in high-risk patients. Correlate LIFE with histology findings. Annual Meeting of American Pulmonary Society. Chest, 2003. e-Pub 2003.
85. Anderson TM, Dougherty TJ, Tan D, Sumlin A, Schlossin JM, Kanter PM. Photodynamic therapy for sarcoma pulmonary metastases: a preclinical canine study. 39th Annual Meeting of the Society of Thoracic Surgeons, Annuls of Thoracic Surgery, 2003. e-Pub 2003.
86. Wiseman S, Stoler D, Anderson, Riguel N, Hicks W, Tan D, Loree T. High Rates Of Intrachromosomal And Chromosomal Instability In Papillary Thyroid Carcinoma Correlates With Aggressive Biological Behavior. AACR Annual Meeting. American Association for Cancer Research Annual Meeting Proceedings, Cellular, Molecular and Tumor Biology 44(107):5975, 2003. e-Pub 2003.
87. Deeb G, Wang J, Ramnath N, Slocum H, Wiseman S, Beck A, Tan D. Altered E-cadherin (E-cad) and epidermal growth factor receptor (EGFR) expressions affect patient survival in non-small-cell lung cancer (NSCLC). Proceedings of American Society of Clinical Oncology, JCO 22,671:2700, 2003. e-Pub 2003.
88. Wiseman S, Tan D, Deeb G, Rajput A. Granulocytic sarcoma of the gastrointestinal tract, ASCO 39th Annual Meeting, Chicago, Illinois, U.S.A. Proceedings of ASCO 22,365:1464, 2003. e-Pub 2003.
89. Tan D, Li Q, Ramnath N, Slocum HK, Wiseman S, Beck A, Anderson T, Loewen G. Evaluation of Her-2/neu protein expression and gene alteration in stage I-IIIA non-small cell lung cancers and in non-neoplastic lung tissue: A survey study using combination of high throughout tissue microarray, immunohistochemistry, and fluorescent in-situ hybridization. AACR Annual Meeting. American Association for Cancer Research Annual Meeting Proceedings, Cancer Research 44(9):2531, 2003. e-Pub 2003.
90. Tan D, Ramnath N, Ibramhi A, Donathe K, Bepler G, Slocum H, Loewen G, Anderson T. Overexpression of the tissue inhibitor of metalloproteinease-1(TIMP-1) protein is a putative prognostic marker in non-small cell lung cancer. ASCO Molecular Therapeutics Symposium, San Diego, 2002. e-Pub 2002.
91. Wiseman S, Loree T, Hicks W, Rigual N, Winston J, Tan D, Anderson G, Stoler D. Anaplastic Thyroid Cancer Evolved From Papillary Carcinoma: Demonstration Of Anaplastic Transformation Utilizing The Inter-simple Sequence Repeat Polymerase Chain Reaction. Educational Consortium Genetics In Oncology Workshop, Stevenson, Washington, 2002. e-Pub 2002.
92. Wiseman S, Loree T, Hicks W, Riguel N, Tan D, Anderson G, Stoler D. Variability of Intratumoral Genomic Instability In Thyroid Cancer: An Insight into Thyroid Tumorigenesis and Evolution. poster presentation at COSM 2002, Boca Raton, Florida, U.S.A, 2002. e-Pub 2002.
93. Cheng CC, Pendyala L, Toth K, Tan D, ZXia Z, Petrelli N, Leichman L, Leichman G. Thymidine phosphorylase(TP) and thymidylate synthetase(TS) mRNA and protein expression in colorectal cancer. Cancer Research 43:1090, 2002. e-Pub 2002.
94. Loewen G, Krauza M, Hyland A, Deeb G, Tan D. Detection of premalignant bronchial epithelial abnormalities in high-risk patients. Journal of Clinical Oncology 21:447A-1784, 2002. e-Pub 2002.
95. Yang J, Swede H, Malik D, Moysich K, Asch H, Brooks J, Tan D. Prognostic Significance of Gelsolin Expression in Non-small Cell Cancer. 91st Annual Meeting of United States and Canadian Academy of Pathology Laboratory Investigation 82(1):330A-1377, 2002. e-Pub 2002.
96. Mudhafer SA, Al-Salameh A, Zou HH, Ramnath N, Anderson T, Brooks JJ, Tan D. Downregulation of p21(WAF1) in carciogenesis and prognosis of non-small cell lung cancer. Laboratory Investigation 82(1):325A-1355, 2002. e-Pub 2002.
97. Bepler G, Todorov I, Ramnath N, Slocum H, Beck A, Brooks J, Loewen G, Hyland A, Humberman J, Tan D. Mcm2-A novel diagnostic marker for early detection of premalignant lesions of the lung. Proceedings of the American Association for Cancer Research,. Cancer Research 42(3), 2001. e-Pub 2001.
98. Anderson TM, Litwin AM, Nwogu CE, Pelow JL, Tan D. Pulmonary tumorlets associated with non-small cell lung cancer. American J Surgery:224S, 2001. e-Pub 2001.
99. Zhu W, Malik D, Beck A, Brooks J, Belper G, Tan D. Loss of heterozygosity of chromosome 3 in non-small cell carcinoma of lung using laser capture microdissection and DNA fragment wave techniques. Modern Pathology 14:237A-1402, 2001. e-Pub 2001.
100. Zaid M, Loree M, Tan D. Eosiniphils as a predictive marker for stromal invasion of Head and neck squamous cell carcinoma. Modern Pathology 14:153A-896, 2001. e-Pub 2001.
101. Ramnath N, Hernandez F, Tan D, Huberman J, Natarajan, Beck A, Hyland A, Bepler G. MCM2 is an independent predictor of survival in patients with non-small cell lung cancer (NSCLC). Lung Cancer:327A-1304, 2001. e-Pub 2001.
102. Al-Mudhafer S, Al-Salameh A, Ryes L, Ramanth N, Anderson T, Tan D. Decreased expression of p16 and p27 in non-small cell lung carcinoma(NSCLC) associated with unfavorable clinical outcome. Modern Pathology 14:216A-1272, 2001. e-Pub 2001.
103. Jun Y, Tan D, Moysich K, Swede H, Bepler G, Michalek A, Asch H. Cigarette Smoking and Gelsolin Expression in Non-Small Cell Lung Cancer. Cancer Research 42:37-195, 2001. e-Pub 2001.
104. Said M, Al-Salameh, Malik DA, Cheney RT, Tan D. Revisitation and utilization of MART- 1(A03) and micropthalmia transcription factor (Mitf) in tumors of neural crest origin, 2001. e-Pub 2001.
105. Aljada I, Malik D, Brooks J, Bepler G, Tan D. Association of reciprocal expression of MMP2/MMP-3 and TIMP-1 with tumorogenesis of non-small cell lung cancer. Modern Pathology 14:216A-1272, 2001. e-Pub 2001.
106. Zhou YT, Quinn P, Ward P, Malik D, Brooks J, Rustum Y, Tan D. Role of loss of heterozygosity(LOH) at 11q24.1-q25 in oncogenesis of head and neck squamous cell carcinoma. Modern Pathology 13(1):141A-823, 2000. e-Pub 2000.
107. Zhou YT, Malik D, Tan D. Role of Novel antibodies (A103 and calrentinin) in Diagnosis of renal tumors. Modern Pathology 13(1):105A-608, 2000. e-Pub 2000.
108. Al-Kasspooles MF, Tan D, Nwogu CE, Kader ME, Anderson TM. Prognostic significance of host immune response in patients with operable lung cancer. Proceedings of American Society of Clinical Oncology. Journal of Clinical Oncology:S905, 2000. e-Pub 2000.
109. Mo G, Zhang J, Tan D. ATP7B Genomics in the chinese population - a systematic whole exon study of ATP7B gene of 1536 chinese patients with probable wilson disease in a CAP-accredited clinical genomic center - USCAP 2018 Annual Meeting.
110. Wang H, Rashid A, Estrella J, Abraham S, Foo W, Taggart M, Tan D, Samdani R, Patel V. Clinicopathologic predictors of long-term responders to trastuzumab-based therapy in stage IV esophageal adenocarcinoma - USCAP 2018 Annual Meeting.

Book Chapters

1. Lai, Z, Tong, YT, Tan, D. Pathology, 265-273, 2022.
2. Dugan M, Tan D. Future of Molecular Diagnostics and Personalized Cancer Therapy. In: Principles of Molecular Diagnostics and Personalized Cancer Medicine, 2013.
3. Kim Q, Tan D. Molecular Diagnostics of Hepatic Neoplasms. In: Principles of Molecular Diagnostics and Personalized Cancer Medicine, 2013.
4. Zhang S, Tan D. Introduction of Molecular Techniques and Instrumentation. In: Principles of Molecular Diagnostics and Personalized Cancer Medicine, 2013.
5. Zhao Q, Tan D. Molecular Diagnostics in Assessment of Cancer Prognosis. In: Principles of Molecular Diagnostics and Personalized Cancer Medicine, 2013.
6. Dhingra S, Tan D. Cancer Stem Cells. In: Principles of Molecular Diagnostics and Personalized Cancer Medicine, 2013.
7. Tan D. Molecular Diagnostics of Colorectal Cancer. In: Principles of Molecular Diagnostics and Personalized Cancer Medicine, 2013.
8. Feng W, Tan D. Proteomics, Morphoproteomics, and Targeted Therapy of Gastric Carcinoma. In: Advances in Surgical Pathology: Gastric Cancer. Lippincott Williams & Wilkins, 2010.
9. Liang J, Tan D. Molecular Biomarkers of Gastric Adenocarcinoma. In: Advances in Surgical Pathology: Gastric Cancer. Lippincott Williams & Wilkins, 2010.
10. Tan D, Payne W. Introduction to the Normal Histology and Physiology of the Stomach. In: Advances in Surgical Pathology: Gastric Cancer. Lippincott Williams & Wilkins, 2010.
11. Goodarzi M, Tan D. Molecular Prognostic Markers of Gastric Cancer. In: Advances in Surgical Pathology: Gastric Cancer. Lippincott Williams & Wilkins, 2010.
12. Tan D. TNM and Concerns in the Staging of Gastric Cancer. In: Advances in Surgical Pathology: Gastric Cancer. Lippincott Williams & Wilkins, 2010.
13. Tan D. Molecular biology of stromal neoplasms of lung. In: Molecular Pathology of Lung Diseases. Springer-Verlag, 2009.
14. Tan D, Zander DS. Pulmonary neoplasms-Immunohistochemistry. In: Foundations in Diagnostic Pathology: Pulmonary Pathology. Elsevier, 786-800, 2008.
15. Tan D, Sadir A. Lung Cancers. In: Foundations in Diagnostic Pathology: Pulmonary Pathology. Elsevier, 544-562, 2008.
16. Tan D. Gastrointestinal Pathology. In: Photographic Atlas of Anatomic Pathology. Sichuan University Press, 67-88, 2008.
17. Tan D. Role of immunohistochemical expression of Cables protein in human cancer. In: Handbooks of Immunohistochemistry and In Situ Hybridization of Human Carcinomas. Elsevier Science.

Books (edited and written)

1. Tan D. Chinese version of Principles of Molecular Diagnositcs and Personalized Cancer Medicine, 2016.
2. Tan D, Lynch H. Principles of Molecular Diagnostics and Personalized Cancer Therapy. Lippincott Williams & Wilkins, 2012.
3. Tan D, Lauwers G. Advances in Surgical Pathology: Gastric Cancer. Ed(s) First. Lippincott Williams & Wilkins, 2010.